Want more tips and tricks for reaching your health goals? Join Lark!

Take our 2-minute survey to find out if you’re eligible to join Lark which includes a smart scale and the chance to earn a Fitbit®.
Start now
*Terms and conditions apply
Close icon
< Back to Resource Center
< Back to Member Blog

Lark Health CEO Julia Hu Awarded UCSF Health Awards Hall of Fame

November 10, 2021

Are you at risk of prediabetes?

Lark can help lower your risk for Type 2 Diabetes through healthy habit formation, and data tracking.
Height: 5 ft 4 in
4' 0"
7' 0"
Weight: 160 lbs
90 lbs
500 lbs
Risk Level
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Hu Joins World’s Top Digital Health Founders With Hall of Fame Recognition

MOUNTAIN VIEW, Calif. —  November 10th—  Julia Hu, CEO and Co-Founder of Lark Health, has been inducted into the University of California, San Francisco (UCSF) Health Awards Hall of Fame. Granted annually to a select few individuals, the prestigious Hall of Fame award honors those who have “made substantial contributions in the field of digital health innovation.” Through this recognition, Julia has been identified as a top innovator and inspiration to the digital health community for her work to transform the delivery of virtual care.

Started in 2019, the UCSF Health Awards recognize “the best new products and technologies” in digital health and life sciences. Of the thousands of applications received since the program began, only ten leaders in the digital health industry have been selected to join the Hall of Fame. Joining her in this year’s recognition are Deborah Kilpatrick, CEO of Evidation Health and Iyah Romm, CEO of Cityblock Health. 

“The UCSF Health Awards Hall of Fame award recognizes excellence in digital health,” said Mark Goldstein, Chairman and Founder, UCSF Health Hub. “Joining the ranks of the UCSF Health Awards Hall of Fame places this year’s inductees among the world's top digital health founders.”

Julia has dedicated her career to developing technology to make the healthcare experience more seamless and accessible. Managing her own lifelong chronic condition has given her a deep, personal understanding of the importance of compassionate, personalized, high-touch care, and she co-founded Lark to deliver that experience to more people with chronic care needs. By working with health plans and employers, Lark provides a seamless and scalable care experience through its AI-powered platform, developed with a Cognitive Behavioral Therapy framework. The result is a transformative, round-the-clock virtual care experience built on industry-leading technology that can reach users throughout their care journey.

“We founded Lark with a commitment to helping anyone with a chronic condition improve their quality of life,” said Julia Hu, co-founder and CEO of Lark. “This mission is deeply personal to me, and I am incredibly honored to receive this recognition from UCSF. This award is a testament to the entire Lark team and our work together to build a virtual solution capable of delivering compassionate, coordinated, and personalized care at scale.”

Julia’s Hall of Fame induction follows a year of significant validation for the company. This month, Lark announced the closing of a $100 million Series D funding round led by Deerfield Management Company. This comes after adding five key members to its executive team, and the publication of peer-reviewed research by Lark’s clinical research team in Frontiers of Digital Health examining older adults’ digital health engagement in August.


About Lark Health

Lark is a healthcare technology company aimed at delivering infinitely scalable, virtual chronic and preventative healthcare through conversational AI. To date, Lark has provided nearly 2 million people with unlimited, 24/7 personalized care delivered through an easy-to-use, text message-like interface that integrates remote patient monitoring tools and is built on a cognitive behavioral therapy framework. Lark’s platform seamlessly integrates with health plans’ and employers’ existing healthcare infrastructure to help them scale their chronic disease prevention and management programs, boost engagement, and improve health outcomes. Lark currently works with many of the largest health plans and across four programs: Prevention, Diabetes Prevention, Diabetes Care, and Hypertension Care. Lark's Diabetes Prevention Program, which is the fastest growing and lowest cost DPP, has received the highest level of clinical recognition—Full Recognition—from the Centers for Disease Control and Prevention. The company has received numerous accolades, including having been named as one of CB Insights Digital Health 150 (2019), a finalist for the UCSF Digital Health Awards (2020), one of Fast Company’s Most Innovative Companies (multiple years), and one of Fierce Healthcare's Fierce 15 (2020). To learn more, visit www.lark.com.

About Lark

Lark helps you eat better, move more, stress less, and improve your overall wellness. Lark’s digital coach is available 24/7 on your smartphone to give you personalized tips, recommendations, and motivation to lose weight and prevent chronic conditions like diabetes.

Read more

Get healthier with Lark & earn a Fitbit®

Lose weight, get more active, and eat better.
take 1-minute survey

Similar posts

Doctor TextingDoctor Texting

Weight Loss Drug Demand Must Be Addressed With New Solutions & Strategies

As the demand for GLP-1 medications continues to soar, health plans and employers must develop a weight management strategy that balances the clinical indications with the financial implications.

Learn more
Mid-Year Pulse: 2023 Health Care Trends Mid-Year Pulse: 2023 Health Care Trends

Mid-Year Pulse: 2023 Health Care Trends

While it’s always tricky to figure out which trends are sustainable and which ones will fade, here are a few we think are going to stick around for the long run.

Learn more
Lark logo and the text 2023Lark logo and the text 2023

Q2 Brief: Lark’s 2023 Published Clinical Studies

We are delighted to announce the results of our latest 2023 clinical studies.

Learn more